Androgen receptor variant 7 (AR-V7) in sequencing therapeutic agents for castratrion resistant prostate cancer: A critical review

BACKGROUND: androgen receptor variant 7 (AR-V7) has been suggested as potential marker for treatment selection in men with metastatic castration-resistant prostate cancer (mCRPC). The aim of the present review is to critically analyze: frequency of the AR-V7 expression in mCRPC cases—impact of AR-V7...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Medicine (Baltimore)
Päätekijät: Sciarra, Alessandro, Gentilucci, Alessandro, Silvestri, Ida, Salciccia, Stefano, Cattarino, Susanna, Scarpa, Susanna, Gatto, Antonio, Frantellizzi, Viviana, Von Heland, Magnus, Ricciuti, Gian Piero, Del Giudice, Francesco, Maggi, Martina
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Wolters Kluwer Health 2019
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6531263/
https://ncbi.nlm.nih.gov/pubmed/31083254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000015608
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia